# Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors

> **NCT00049608** · PHASE1 · TERMINATED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)** · enrollment: 51 (estimated)

## Conditions studied

- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Pancreatic Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** mistletoe extract
- **DRUG:** gemcitabine hydrochloride

## Key facts

- **NCT ID:** NCT00049608
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2011-08
- **Target enrollment:** 51 (ESTIMATED)
- **Why stopped:** Principal investigator \[PI\] has left institution.
- **Last updated:** 2013-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00049608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00049608, "Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00049608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*